News

Varonis Systems Faces Downgrades Post Disappointing Earnings

Varonis Systems Faces Downgrades Post Disappointing Earnings

Varonis Systems Reports Q3 Earnings and Guidance

Varonis Systems Inc (NASDAQ: VRNS) has recently revealed disappointing results for its third quarter, with revenue figures falling short of market expectations. Their reports indicated earnings of 6 cents per share, aligning with the analysts' consensus, but the total revenue came in at $161.577 million, which significantly missed the anticipated $166.149 million.

Fourth Quarter Expectations

Looking ahead, Varonis expects adjusted earnings per share for the fourth quarter to be between 2 cents and 4 cents, falling below market projections of 5 cents. Additionally, the company forecasts sales in the range of $165.00 million to $171.00 million. This also contrasts with earlier estimates which were set at $170.129 million.

CEO Comments on SaaS Demand

Yaki Faitelson, the CEO of Varonis, stated that despite the recent downturn, there remains a robust demand for their Software as a Service (SaaS) platform. This service now constitutes about 76% of their total Annual Recurring Revenue (ARR). He attributed this ongoing interest to the automated solutions the platform provides and the growing customer focus toward implementing AI initiatives and securing data in the cloud.

Challenges Faced

However, Faitelson also noted challenges faced in the last weeks of the quarter, particularly lower renewal rates in both Federal and non-Federal on-premises subscription businesses. These issues contributed to the company’s disappointing financial outcomes.

Stock Performance and Analyst Ratings

In response to the earnings news, Varonis Systems' stock fell by 45.2%, trading at $34.53. Following the release of these quarterly earnings, several analysts adjusted their price targets for the stock:

Changes in Price Targets

1. Mike Cikos from Needham retained a Buy rating but lowered the price target from $70 to $55.

2. Saket Kalia from Barclays maintained an Overweight rating while adjusting the price target from $70 to $50.

3. Neutral ratings were kept by Rob Owens from Piper Sandler, who reduced the target price from $50 to $45.

4. Jonathan Ruykhaver at Cantor Fitzgerald kept his Overweight rating and adjusted the price target from $70 to $60.

5. Shyam Patil from Susquehanna maintained a Positive outlook, cutting the price target from $65 to $50.

6. Junaid Siddiqui from Truist Securities reiterated a Buy rating, slashing the price target from $70 to $50.

7. Roger Boyd at UBS continued to endorse Varonis Systems with a Buy rating but lowered the price target from $70 to $60.

Analytical Insights

For those considering purchasing VRNS stock, it's crucial to be aware of the mixed analyst sentiments following the earnings report. While some maintain optimism about the company's growth potential in the SaaS domain, the immediate financial outlook remains uncertain.

Frequently Asked Questions

What were Varonis Systems' earnings for Q3?

For Q3, Varonis reported earnings of 6 cents per share, meeting analyst expectations.

How did Varonis' revenue compare to expectations?

Varonis' revenue of $161.577 million fell short of the anticipated $166.149 million.

What does the fourth-quarter guidance indicate?

Varonis expects adjusted EPS of 2 to 4 cents and revenue of $165 million to $171 million for Q4.

What has been the market reaction to the earnings report?

The stock price of Varonis Systems dropped by 45.2%, closing at $34.53.

What analysts say about Varonis' stock?

Various analysts have downgraded their price targets, reflecting skepticism about Varonis' short-term performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading

Top 5 Most Recently Viewed Articles

UJET Secures $76 Million Funding Boost to Enhance AI Solutions

Updated Category News Views 49

UJET Secures Major Funding to Advance AI Innovations UJET, Inc., a leading name in AI-powered cloud contact center solutions, has proudly announced the successful completion of its latest funding round. This impressive Series D funding raised a total of $76 million, spearheaded by Sapphire Ventures, with significant contributions from investors like KeyCorp and...

Continue Reading
Vantage Strengthens Cloud Cost Management with FinOps Membership

Updated Category News Views 165

Vantage Becomes a Premier Member of the FinOps Foundation Vantage, well-known for its leadership in cloud cost management, is thrilled to announce that it has joined the FinOps Foundation. This step marks a pivotal moment for the company as it commits to enhancing cloud financial operations. Vantage provides actionable insights that empower engineers with the necessary...

Continue Reading
EDAP TMS Reports Successful FARP Trial Outcomes for Prostate Cancer

Updated Category News Views 180

Positive Results from the FARP Trial Announced EDAP TMS SA (Nasdaq: EDAP), a frontrunner in robotic energy-based therapies, has recently announced encouraging results from its Focal Ablation Versus Radical Prostatectomy (FARP) randomized controlled trial (RCT). This groundbreaking study was designed to compare the efficacy of ultrasound energy-based focal ablation with...

Continue Reading
Lawsuit Filed Over Alleged Risks Linked to Neptune's Fix Elixir

Updated Category News Views 126

Examining the Legal Case Against Neptune Resources A significant legal case has captured the public's attention. The law firm Feldman Shepherd Wohlgelernter Tanner Weinstock Dodig LLP is taking action on behalf of the family of a young man named Matthew Cornier, who tragically passed away after using Neptune's Fix Elixir. The 32-year-old Cornier, a skilled Graphic Design...

Continue Reading
Exploring Nature’s Sunshine's Upcoming Financial Insights Call

Updated Category News Views 162

Nature’s Sunshine Announces Conference Call for Financial Results Nature’s Sunshine Products, Inc. (Nasdaq: NATR) is gearing up to share exciting insights into its financial performance with a conference call set for a specified future date. This call is an excellent opportunity for stakeholders and interested parties to learn more about the company’s latest...

Continue Reading